Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

On Jan. 29, the University’s Integrative Learning and Life Design Lab hosted the first inaugural industry-specific career ...

ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...

A brand-new addition this year is the Pittcon Pups – meet adorable local dogs of all ages looking for their fur-ever home. Whether you’re just there for some puppy snuggles or hoping to meet your new ...

According to Instarem’s global head, Yogesh Sangle, “While corporate income tax rebates are a welcome measure for profitable ...

A groundbreaking leader in Biotech was a guest speaker Thursday night at the Hatfield Hall Theater at Rose Hulman. Nina Tandon, the CEO and Co-founder of EpiBone, delivered a special address to ...

Metsera is a clinical-stage biotechnology company developing injectable and oral treatments for obesity and related conditions, the filing shows. The company’s investors include affiliates of ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.

The notion of a single lifelong career is becoming a relic of the past. A growing number of seasoned professionals are embarking on entirely new career paths, a trend that reflects shifting ...